Alzheimer's disease is one of the most devastating neurodegenerative disorders. As the disease progresses, memory and cognitive functions decline, and behavioral changes and restlessness may also occur. In the brain, the accumulation of amyloid-beta proteins and abnormalities in the tau protein play an important role, among others.

Despite the enormous amount of research, there is still no treatment that can cure Alzheimer's. That is precisely why it is interesting that in recent years, scientists have been increasingly looking at a system that is already naturally present in our body: the endocannabinoid system (ECS).

In his recent article 'Cannabis opens new doors in Alzheimer's', Peter Vermeul explores what the current scientific literature tells us about this. In doing so, he does not only look at CBD or THC as individual substances, but precisely at the broader whole of cannabinoids, cannabinoid acids, terpenes, flavonoids, and sterols that occur together in a Full Spectrum cannabis extract.

And that broader perspective is precisely what makes the research particularly interesting.